These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

410 related items for PubMed ID: 16951477

  • 21. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y.
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Accumulation of microdamage in bone].
    Mori S.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():203-8. PubMed ID: 18161107
    [No Abstract] [Full Text] [Related]

  • 24. Once-yearly administered intravenous zoledronic acid for postmenopausal osteoporosis.
    Woodis CB.
    Ann Pharmacother; 2008 Jul 28; 42(7):1085-9. PubMed ID: 18505912
    [Abstract] [Full Text] [Related]

  • 25. Is there an advantage to an injected bisphosphonate versus a daily or monthly oral regimen?
    Mayo Clin Womens Healthsource; 2008 Sep 28; 12(9):8. PubMed ID: 18667976
    [No Abstract] [Full Text] [Related]

  • 26. Effects of ibandronate on bone quality: preclinical studies.
    Bauss F, Dempster DW.
    Bone; 2007 Feb 28; 40(2):265-73. PubMed ID: 16996333
    [Abstract] [Full Text] [Related]

  • 27. Consultation corner. Bone loss drug gives users a break.
    Bellantoni M.
    Johns Hopkins Med Lett Health After 50; 2007 Dec 28; 19(10):6. PubMed ID: 18225340
    [No Abstract] [Full Text] [Related]

  • 28. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
    Tanaka M, Mori H, Kayasuga R, Ochi Y, Kawada N, Yamada H, Kishikawa K.
    Bone; 2008 Nov 28; 43(5):894-900. PubMed ID: 18687415
    [Abstract] [Full Text] [Related]

  • 29. What to make of the new warning on bisphosphonates. Officials acknowledge a connection between the most popular bone drugs and rare thigh fractures.
    Harv Womens Health Watch; 2010 Dec 28; 18(4):6-7. PubMed ID: 21268797
    [No Abstract] [Full Text] [Related]

  • 30. [Biochemical markers of bone turnover. New aspect. Biochemical markers of bone turnover in long term treatment with bisphosphonate].
    Asano S, Suzuki A, Itoh M.
    Clin Calcium; 2009 Aug 28; 19(8):1179-85. PubMed ID: 19638702
    [Abstract] [Full Text] [Related]

  • 31. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG.
    Bone; 2008 Oct 28; 43(4):653-62. PubMed ID: 18582604
    [Abstract] [Full Text] [Related]

  • 32. [Long-term and high-dose bisphosphonate administration causes no bone over-mineralization].
    Liu C, Cao YP, Yang X, Mashiba T, Mori S.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 17; 89(42):2968-71. PubMed ID: 20137705
    [Abstract] [Full Text] [Related]

  • 33. [Diabetes mellitus and bisphosphonate-related osteonecrosis of the jaws].
    Urade M.
    Clin Calcium; 2009 Sep 17; 19(9):1332-8. PubMed ID: 19721206
    [Abstract] [Full Text] [Related]

  • 34. Bisphosphonate dose and incidence of fractures in postmenopausal osteoporosis.
    Makras P, Hamdy NA, Zwinderman AH, Ballieux BE, Papapoulos SE.
    Bone; 2009 May 17; 44(5):766-71. PubMed ID: 19442613
    [Abstract] [Full Text] [Related]

  • 35. What is new in the treatment of steroid-induced osteoporosis?
    Liu RH, Werth VP.
    Semin Cutan Med Surg; 2007 Dec 17; 26(4):203-9. PubMed ID: 18395668
    [Abstract] [Full Text] [Related]

  • 36. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
    Schneider JP.
    Geriatrics; 2009 Jan 17; 64(1):18-23. PubMed ID: 19256578
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Avascular mandibular osteonecrosis in association with bisphosphonate therapy: a report on four patients.
    Friedrich RE, Blake FA.
    Anticancer Res; 2007 Jan 17; 27(4A):1841-5. PubMed ID: 17649782
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.